Hillege, Hans L.

Defining the role of common variation in the genomic and biological architecture of adult human height

The Electronic Medical Records and Genomics (eMERGE) Consortium, Wood, A. R., The MIGen Consortium, The PAGE Consortium, Study, T. L. C., Esko, T., Yang, J., Vedantam, S., Pers, T. H., Gustafsson, S., et al. (2014) · Nature Genetics

Genetic Associations and EpidemiologyGenetics and Physical Performance

Cited by 1,853

New genetic loci link adipose and insulin biology to body fat distribution

The ADIPOGen Consortium, Shungin, D., The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The GEFOS Consortium, The GENIE Consortium, The, G. L. G. C., The, I. C. B. P., The International Endogene Consortium, Study, T. L. C., et al. (2015) · Nature

Genetic Associations and EpidemiologyAdipokines, Inflammation, and Metabolic Diseases

Cited by 1,580

Lenient versus strict rate control in patients with atrial fibrillation

Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine

Atrial Fibrillation Management and OutcomesHeart rate and cardiovascular health

Cited by 1,033

Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

Hillege, H. L., Nitsch, D., Pfeffer, M. A., Swedberg, K., McMurray, J. J. V., Yusuf, S., Granger, C. B., Michelson, E. L., Östergren, J., Cornel, J. H., et al. (2006) · Circulation

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 945

Anemia and Mortality in Heart Failure Patients

Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology

Erythropoietin and Anemia TreatmentHeart Failure Treatment and Management

Cited by 764

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

Brouwers, F. P., de Boer, R. A., van der Harst, P., Voors, A. A., Gansevoort, R. T., Bakker, S. J., Hillege, H. L., van Veldhuisen, D. J., & van Gilst, W. H. (2013) · European Heart Journal

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 610

The Association of Obesity and Cardiometabolic Traits With Incident HFpEF and HFrEF

Savji, N., Meijers, W. C., Bartz, T. M., Bhambhani, V., Cushman, M., Nayor, M., Kizer, J. R., Sarma, A., Blaha, M. J., Gansevoort, R. T., et al. (2018) · JACC: Heart Failure

Cardiovascular Function and Risk FactorsHeart Failure Treatment and Management

Cited by 499

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

Rienstra, M., Hobbelt, A. H., Alings, M., Tijssen, J. G. P., Smit, M. D., Brügemann, J., Geelhoed, B., Tieleman, R. G., Hillege, H. L., Tukkie, R., et al. (2018) · European Heart Journal

Atrial Fibrillation Management and OutcomesCardiac Health and Mental Health

Cited by 313

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality

Vermond, R. A., Geelhoed, B., Verweij, N., Tieleman, R. G., Van der Harst, P., Hillege, H. L., Van Gilst, W. H., Van Gelder, I. C., & Rienstra, M. (2015) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 297

C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study

Voors, A. A., von Haehling, S., Anker, S. D., Hillege, H. L., Struck, J., Hartmann, O., Bergmann, A., Squire, I., van Veldhuisen, D. J., Dickstein, K., et al. (2009) · European Heart Journal

Heart Failure Treatment and ManagementAcute Myocardial Infarction Research

Cited by 222

Quality of life and depressive symptoms in the elderly: A comparison between patients with heart failure and age- and gender-matched community controls

Lesman-Leegte, I., Jaarsma, T., Coyne, J. C., Hillege, H. L., Van Veldhuisen, D. J., & Sanderman, R. (2009) · Journal of Cardiac Failure

Cardiac Health and Mental HealthHeart Failure Treatment and Management

Cited by 198

The Effect of Rate Control on Quality of Life in Patients With Permanent Atrial Fibrillation

Groenveld, H. F., Crijns, H. J. G. M., Van den Berg, M. P., Van Sonderen, E., Alings, A. M., Tijssen, J. G. P., Hillege, H. L., Tuininga, Y. S., Van Veldhuisen, D. J., Ranchor, A. V., et al. (2011) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studies

Cited by 164

The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population

Gansevoort, R. T., Verhave, J. C., Hillege, H. L., Burgerhof, J. G. M., Bakker, S. J. L., De Zeeuw, D., & De Jong, P. E. (2005) · Kidney International

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 163

Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium

Shin, J.-I., Chang, A. R., Grams, M. E., Coresh, J., Ballew, S. H., Surapaneni, A., Matsushita, K., Bilo, H. J. G., Carrero, J. J., Chodick, G., et al. (2021) · Hypertension

Chronic Kidney Disease and DiabetesBlood Pressure and Hypertension Studies

Cited by 155

Preferences of heart failure patients in daily clinical practice: Quality of life or longevity?

Kraai, I. H., Vermeulen, K. M., Luttik, M. L. A., Hoekstra, T., Jaarsma, T., & Hillege, H. L. (2013) · European Journal of Heart Failure

Health Systems, Economic Evaluations, Quality of LifeHeart Failure Treatment and Management

Cited by 147

Heart Failure Patients Monitored With Telemedicine: Patient Satisfaction, a Review of the Literature

Kraai, I. H., Luttik, M. L. A., de Jong, R. M., Jaarsma, T., & Hillege, H. L. (2011) · Journal of Cardiac Failure

Telemedicine and Telehealth ImplementationHeart Failure Treatment and Management

Cited by 78

Implementing managed entry agreements in practice: The Dutch reality check

Makady, A., van Veelen, A., de Boer, A., Hillege, H., Klungel, O. H., & Goettsch, W. (2019) · Health Policy

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 61

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

Abbasi, A., Corpeleijn, E., Gansevoort, R. T., Gans, R. O. B., Struck, J., Schulte, J., Hillege, H. L., van der Harst, P., Stolk, R. P., Navis, G., et al. (2014) · Diabetologia

Redox biology and oxidative stressAdipokines, Inflammation, and Metabolic Diseases

Cited by 27

Conditional Financing of Drugs in the Netherlands: Past, Present, and Future—Results From Stakeholder Interviews

Makady, A., van Acker, S., Nijmeijer, H., de Boer, A., Hillege, H., Klungel, O., & Goettsch, W. (2019) · Value in Health

Pharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life

Cited by 22